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Proto-oncogene FBI-1 (Pokemon/ZBTB7A) Represses
Transcription of the Tumor Suppressor Rb Gene via Binding
Competition with Sp1 and Recruitment of Co-repressors*□S
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FBI-1 (also called Pokemon/ZBTB7A) is a BTB/POZ-domain
Kru¨ppel-like zinc-finger transcription factor. Recently, FBI-1
was characterized as a proto-oncogenic protein,which represses
tumor suppressor ARF gene transcription. The expression of
FBI-1 is increased in many cancer tissues. We found that FBI-1
potently represses transcription of the Rb gene, a tumor sup-
pressor gene important in cell cycle arrest. FBI-1 binds to four
GC-rich promoter elements (FREs) located at bp308 to188
of the Rb promoter region. The Rb promoter also contains two
Sp1 binding sites: GC-box 1 (bp65 to56) and GC-box 2 (bp
18 to9), the latter of which is also bound by FBI-1.We found
that FRE3 (bp 244 to 236) is also a Sp1 binding element.
FBI-1 represses transcription of theRb gene not only by binding
to the FREs, but also by competingwith Sp1 at theGC-box 2 and
the FRE3. By binding to the FREs and/or the GC-box, FBI-1
represses transcription of theRb gene through its POZ-domain,
which recruits a co-repressor-histone deacetylase complex and
deacetylates histonesH3 andH4 at theRb gene promoter. FBI-1
inhibits C2C12 myoblast cell differentiation by repressing Rb
gene expression.
The importance of the tumor suppressor retinoblastoma
(Rb)3 protein in regulating key cellular events was first sug-
gested by the identification of a tumor, retinoblastoma, in
which the Rb locus was invariably deleted (1–3). Rb is impli-
cated in the development of various cancers (4 and references
therein). Rb suppresses tumorigenesis by inhibiting cell cycle
progression at G1/S by preventing the transcription of several
genes important in cell cycle control (5). Rb is phosphorylated
in a cell cycle-dependent manner (6 and references therein).
When Rb is hypophosphorylated, it forms complexes with E2F
family proteins and inhibits transcription by recruiting proteins
involved in transcriptional repression (7). Once phosphoryla-
ted, Rb can no longer form complexes with E2F proteins. E2F
proteins, upon dimerization with their differentiation-regu-
lated transcription factor partners, are capable of activating the
expression of a number of genes that are likely to regulate or
promote entry into S phase (6 and references therein).
Investigations on how transcription of the Rb gene is regu-
lated are important in elucidating the cellular regulatorymech-
anism of Rb gene expression (8–12). For example, induction of
Rb gene transcription by MyoD, via CREB, is a key event in
muscle differentiation (9). Furthermore, transcriptional activa-
tion of the Rb gene by GABP and HCF-1 is also important in
muscle differentiation (10, 11). In contrast, YY1 and MIZF
repress transcription of Rb, and this repression is important for
inhibiting myogenesis (10, 12). All these data suggest that mul-
tiple transcription factors act on the transcriptional regulation
of Rb gene.
We have been investigating the biological functions of FBI-1
(also called Pokemon/ZBTB7A), which contains a BTB/POZ-
domain at its N terminus and Kru¨ppel-like zinc fingers at its C
terminus (13, 14). Recently, there have been several reports on
the function of FBI-1. FBI-1 stimulates the Tat activity of
human immunodeficiency virus, type 1 long terminal repeat
and represses human ADH5/FDH gene expression by interact-
ing with Sp1 zinc fingers (14, 15). The mouse counterpart of
FBI-1, LRF, co-immunoprecipitates and co-localizes with
Bcl-6, and is involved in chondrogenesis and adipogenesis (16–
18). The rat homolog of FBI-1, OCZF, is a transcriptional
repressor and is involved in osteoclastogenesis (19). FBI-1
enhances NF-B-mediated transcription through an interac-
tion between the POZ-domain of FBI-1 and the RHD of NF-B
(20). Recently, FBI-1 was identified as a proto-oncogene (21).
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Serial analysis of gene expression analysis showed that the
expression of FBI-1 is increased in cancer tissues. In transgenic
mice overexpressing FBI-1, FBI-1 represses transcription of
tumor suppressor gene,ARF, by binding to its promoter region.
The product of ARF is a transcriptional activator of p53,
another tumor suppressor. Thus, repression of ARF can even-
tually inhibit expression of p53, promoting oncogenesis in the
thymus, liver, and spleen. In FBI-1 knockout mice, overexpres-
sion of ARF increases expression of p53, induces senescence,
apoptosis, and eventually blocks cellular differentiation (21).
FBI-1 is overexpressed in solid tumors, such as cancers of the
colon and bladder, in which the normal function of the ARF/
p53 pathway is frequently lost. It is likely that FBI-1 hasmultiple
additional target genes by which it can exert oncogenic activity
(22 and references therein).
We suspected that FBI-1 might be involved in the transcrip-
tional regulation of the genes involved in differentiation, cell
cycle control, and tumor suppression, such as Rb. We found
that the Rb gene is the molecular target of proto-oncogene
FBI-1, and we investigated the molecular mechanism of tran-
scriptional regulation in detail.
EXPERIMENTAL PROCEDURES
Plasmids Construction—pGL3-Enhancer-Rb-Luc plasmid
was kindly provided by Dr. Masayuki Sekimata (Fukushima
Medical University, Japan) (12, 23). The pGL2-Rb-Luc fusion
plasmid was prepared by cloning the Rb promoter (bp370 to
106) into the pGL2-Basic plasmid (Promega, Madison, WI).
Various mutant Rb-Luc plasmids were prepared using a site-
directed mutagenesis kit (Stratagene). Expression plasmid vec-
tors for the VP16-co-repressors, BCoR (aa 112–753), NCoR (aa
1709–2215), and SMRT (aa 194–657) fusion proteins
(pKH135EF-BCoR, pKH73/110EF-NCoR, and pCMX-SMRT)
were reported elsewhere (24). Construction of pcDNA3-FBI-1,
pcDNA3-FBI-1POZ, and pG5-Luc were reported elsewhere
(14). To prepare the recombinant GST-POZFBI-1 fusion pro-
tein expression vector, a cDNA fragment encoding the POZ-
domain of FBI-1 was subcloned into pGEX4T3 (Amersham
Biosciences) (14). The expression vectors for Sp1ZFDBD (zinc
finger DNA binding domain) (aa 624–718) and FBI-1ZFDBD
(aa 366–495) was prepared by cloning the PCR-amplified
cDNA fragments into pGEX4T1 (24, 25). The oligonucleotide
primersused forPCRamplificationofFBI-1ZFDBDareas follows:
forward, 5-GATCGGATCCGCCTGGTCGCAGAAGGTG-
GAG-3 and reverse, 5-GATCGTCGACCGAGGGGACGC-
CGTTGCAGCCGTC-3.
Mammalian expression vectors for the co-repressors used in
GST-pulldown assays were prepared by subcloning the cDNA
fragments encoding BCoR (aa 112–753), NCoR (aa 1709–
2215), and SMRT (aa 194–657) into pcDNA3.0 (Invitrogen) as
reported elsewhere (24). The FBI-1 expression vector in Dro-
sophila SL2 cells was prepared by cloning FBI-1 cDNA into
pPac-PL provided by Dr. Carl Thummel (University of Utah).
pPac-Sp1 was provided by Dr. Robert Tjian (University of Cal-
ifornia, Berkeley, CA).
Cell Culture/Stable Cell Line—HeLa cells were cultured in
Dulbecco’smodified Eagle’smedium (DMEM, Invitrogen) sup-
plemented with 10% fetal bovine serum (Invitrogen). Stable
HeLa cells overexpressing FBI-1 were prepared by transfecting
HeLa cells with a recombinant Lenti virus, LentiM1.4-FBI-1-
FLAG. Control stable cells were prepared using recombinant
LentiM1.4-LacZ virus. Drosophila SL2 cells were cultured in
Schneider’s medium (Invitrogen) supplemented with 10% fetal
bovine serum.
Transcription Analysis of the Rb Gene Promoter—HeLa,
HCT116, and HEK 293A cells were cultured with the medium
recommended by the ATCC (Manassas, VA) on 6-well culture
vessels andwere transfectedwith 0.3g of pGL2-Rb-LucWt or
mutants and 0.5 g each of pcDNA3.0, pcDNA3.0-FBI-1, and
pcDNA3.0-FBI-1POZ using Lipofectamine Plus reagent
(Invitrogen). After 36 h of incubation, cells were harvested,
lysed, and assayed for luciferase activities. Luciferase activity
was normalized with the protein concentration of the lysate.
Electrophoretic Mobility Shift Assays—EMSAs were carried
out as described previously (24). Binding reactions were carried
out in 20l of binding buffer containing 10mMHEPES, pH7.9, 60
mMKCl, 5MZnCl2, 1 mM dithiothreitol, 1% bovine serum albu-
min, 7% glycerol, 0.1 g of recombinant FBI-1ZFDBD or
Sp1ZFDBD, and 10,000 cpmof probe at room temperature for 30
min. Antibodies againstGST-Tag, FBI-1, or Xpresswere added to
bindingreactions for supershiftof theprobe-proteincomplex.The
sequences of FREs and Sp1-binding GC-box oligonucleotides
were as follows (only the top strand sequences are shown): FRE1,
5-GATCGGATGAGGCCCACAGTCACC-3; FRE2,5-GATC-
CCACAGTCACCCACCAGACT-3; FRE3, 5-GATCAGGGG-
GTGGTTCTGGGTAGA-3; FRE4, 5-GATCCGCCTGGAC-
CCACGCCAGGT-3; GC-box 1, 5-GATCACGGGCGGAAG-
TGAC-3; and GC-box 2, 5-GATCAGTTGCCGGGCGGGG-
GAGGG-3.
Site-directed Mutagenesis of the Rb Promoter—To investigate
the roleofFBI-1bindingsiteson transcription,mutationswere intro-
duced into the promoter sequence using the QuikChange site-di-
rected mutagenesis kit (Stratagene, La Jolla, CA). The core GGG of
the binding sequences (5-GDGGGYYYY-3) of the FREs and the
GC-boxes was replaced with AAA using the following mutagenesis
oligonucleotides primers (only the top strands are shown): mFRE1,
5-CCCGGGATAGGGATGAAATTTACAGTCACCCACC-
AGA-3; mFRE2, 5-ATGAGGCCCA; CAGTCATTTACCA-
GACTCTTTGTAT-3; mFRE3, 5-CACCCCGGCCTGGAG-
GAAAAAATTCTGGGTAGAAGCAC-3; mFRE4, 5-CTG-
GAAGGCGCCTGGATTTACGCCAGGTTTC; CCAG-3;
mGC-Box 1, 5-ACGTGACGCCGCGGGCAAAAGTGACG-
TTTTCCCG-3; and mGC-Box 2, 5-CGCTCAGTTGCCGG-
GCAAGGGAGGGCGCGTCCGG-3.
Mammalian Two-hybrid Assays—African green monkey
kidney cells (CV-1) were grown in DMEM supplemented with
10% fetal bovine serum (Invitrogen). CV-1 cells were tran-
siently transfectedwith pCMX-Gal4-POZFBI-1, pCMX-VP16-
BCoR, pCMX-VP16-NCoR, pCMX-VP16-SMRT, and pG5-
Luc using Lipofectamine Plus reagent (Invitrogen). Cells were
cultured for 36 h. The cells were then harvested, lysed, and
analyzed for luciferase activity on a luminometer (Microplate
Luminometer LB 96V, EG&G Berthold, MD). Luciferase activ-
ity was normalized with the cotransfected -galactosidase
activity or protein concentration.
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GST Fusion Protein Pulldown Assays—Escherichia coli
BL21(DE3), transformed with either GST or GST fusion pro-
tein expression vector, was induced with 0.5 mM isopropyl-1-
thio--D-galactopyranoside for 4 h at 37 °C. After E. coli pellets
were lysed and sonicated in lysis buffer (1phosphate-buffered
saline, 1 mM phenylmethysulfonyl fluoride, 2 mM EDTA, and
0.2 mg/ml lysozyme), recombinant proteins were purified by
affinity chromatography using glutathione-agarose 4 beads
(Peptron, Daejeon, Korea). Purified proteins were resolved on a
12% SDS-PAGE gel to quantitate them and assess their purity.
The same volume of protein-agarose bead complex was used
for all GST fusion protein pulldown assays.
Co-repressor proteins were prepared in vitro by incubating 1
g of the pcDNA3.0 co-repressor expression vector with TNT
Quick-coupled Transcription/Translation Extract (Promega),
containing 40l of TNTQuickMasterMix and 2l of [35S]me-
thionine (1175.0 Ci/mol, PerkinElmer Life Sciences) at 30 °C
for 90 min.
Purified GST fusion proteins (5 g) were incubated with
GSH-agarose for 1 h at 4 °C inHEMGbuffer (40mMHEPES, pH
7.9, 100 mM KCl, 0.2 mM EDTA, 5 mM MgCl2, 0.1% Nonidet
P-40, 10% glycerol, 1.5 mM dithiothreitol, protease inhibitor
mixture (1 tablet/50 ml)). After agarose-GST protein com-
plexes were washed, 10 l of in vitro translated [35S]methi-
onine-co-repressor was added, and this mixture was incubated
in HEMG buffer for 4 h at 4 °C. The reactions mixtures were
centrifuged, and the pellets were washed thoroughly with cold
binding buffer. Bound proteins were separated on a 12% SDS-
PAGE gel, and the gels were exposed to x-ray film using an
image-intensifying screen (Kodak).
Chromatin Immunoprecipitation Assays—The binding of
FBI-1totheFREelementsontheRbpromoter invivowasanalyzedby
ChIP assays. Sub-confluent HeLa cells on a 10-cm dish were trans-
fectedwith3gofpcDNA3.0orpcDNA3.0-FBI-1-FLAGusingLipo-
fectamine Plus (Invitrogen) and grown for an additional 48 h. The
HeLa cells were treated with formaldehyde (final 1%) to cross-link
FBI-1totheRbpromoter.TheremainderoftheChIPassayprocedure
was performed as reported previously (14). To amplify the proximal
and distal promoter regions of the Rb gene, PCR reactions of the
immunoprecipitated DNAwere carried out using the following sets
of oligonucleotide primers: distal FRE region (bp370 to147: for-
ward primer, 5-CACTAGCCAGATATTCCCTGCGGGG-3 and
reverse primer, 5-TAAGTCATGAGGAATTAAACTGGGA-3),
proximalGC-box/FRE region (bp131 to93: forward primer, 5-
CACCGACCAGCGCCCCAGTTCCCCA-3andreverseprimer,5-
GGGAGGACGCGCGCGCACGTCG-3) anddownstream3UTR
region (bp 176326 to 176626: forward primer, 5-GGAT-
CTCAGGACCTTGGTGG-3 and reverse primer, 5-AGGGC-
CATTCTTACTATCCA-3).
The binding competition between FBI-1 and Sp1 on the Rb
promoter in vivowere analyzed byChIP assays in theHEK293A
cells transfected with pcDNA3.1-FBI-1 expression vector (1, 2,
and 4 g) or knockdown siRNA and also in Drosophila SL2
cells. Drosophila SL2 cells lacking mammalian transcription
factors were transfected with pGL2-Rb-Luc, pPac-PL, pPac-
Sp1 (2g), and pPac-FBI-1 (1, 2, 4g) using Cellfectin (Invitro-
gen) and grown for an additional 48 h. The cells were fixed with
formaldehyde (final 1%) to cross-link FBI-1 and Sp1 protein
onto theRb promoter. The remaining ChIP procedure was per-
formed as described previously (14). PCR was performed using
the following cycling conditions: denaturation at 94 °C for 5
min, followed by 35 cycles of 94 °C for 30 s, 55 °C for 30 s, 72 °C
for 30 s, and a final extension reaction at 72 °C for 5 min. We
investigated whether co-repressor (BCoR) binding to the Rb pro-
moter isdependentonFBI-1usingChIP.HEK293Acellsgrownon
10-cm dishes were transfected with pcDNA3-FLAG-FBI-1 (3g)
and/or pCMV-BCoR (3 g). Chromatins were immunoprecipi-
tated using anti-Myc or anti-FLAG antibody; the remaining ChIP
procedures were performed as described above. Oligonucleotide
primers used to amplify the distal FRE cluster region (bp370 to
147) are described above.
We also investigated whether the acetylation status of his-
tones H3 and H4 of nucleosomes at the proximal Rb gene pro-
moter aremodified by ectopic FBI-1 using antibodies specific to
Ac-HistoneH3 andAc-HistoneH4 (Upstate). The oligonucleo-
tide primers used to amplify the Rb gene promoter region (bp
133 to167) flanking the transcription start site were as fol-
lows: forward, 5-CACCGACCAGCGCCCCAGTTCCCCA-
3; reverse, 5-CCTGACGAGAGGCAGGTCCT-3.
Knockdown of FBI-1mRNAby siRNA—The siRNAs designed
to knock down glyceraldehyde-3-phosphate dehydrogenase
and FBI-1 were purchased from Ambion Inc. (Austin, TX).
Their sequences were as follows: siFBI-1 #1, 5-GCUGGACC-
UUGUAGAUCAAtt-3 and 5-UUGAUCUACAAGGUCCA-
GCtt-3; siFBI-1 #2, 5-AGUACCUCGAGUUCUUCCAtt-3
and 5-UGGAAGAACUCGAGGUACUtt-3. The siRNAs for
FBI-1 (20 ng of each) were transfected into 6  106 HEK293A
cells using Lipofectamine 2000 (Invitrogen). After culturing for
72 h, cells were harvested, and analyzed for protein and mRNA
expression by Western blot and RT-PCR, respectively.
Co-immunoprecipitation Assays—The FLAG-FBI-1 and
Myc-BCoR expression vectors were co-transfected, and cells
were washed, pelleted, and resuspended in lysis buffer supple-
mented with protease inhibitors (20 mM Tris-HCl, pH 7.5, 150
mM NaCl, 10% glycerol, 1% Triton X-100). Cell lysates were
pre-cleared, and the supernatant was incubated with anti-Myc
antibody on a rotating platform overnight at 4 °C, followed by
incubation with protein A-agarose beads (Santa Cruz Biotech-
nology, Santa Cruz, CA). Beads were collected, washed, and
resuspended in equal volume of 5 SDS loading buffer (10%
SDS, 10mMdithiothreitol, 20% glycerol, 0.2 MTris-HCl, pH6.8,
0.05% Bromphenol Blue). Immunoprecipitated proteins were
separated by 12% SDS-PAGE. Western blot analysis was per-
formed as described under “Western Blot Analysis.”
Reverse Transcription and PCR—Total RNA was isolated
from the cells using TRIzol reagent (Invitrogen). The DNAs
were synthesized in a 20-l reaction tube containing 5 g of
total RNA, 10 pmol of randomhexamer, and 200 units of super-
script reverse transcriptase II. PCR cycling conditions were as
follows: denaturation at 94 °C for 5min, 23 cycles of at 94 °C for
30 s, 62 °C for 30 s, and 72 °C for 40 s, and a final extension at
72 °C for 7 min. The PCR primers used for FBI-1 cDNA were
5-GGCCTGCTGTGCGACGTGGT-3 and 5-CAGCAG-
GCGGGCGGCGCTGA-3. The primers for Rb were 5-AAA-
GAAAAAGGAACTGTGGG-3 and 5-AACTGCTGGGTT-
GTGTCAAA-3. The primers for glyceraldehyde-3-phosphate
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dehydrogenase (GAPDH) were 5-ACCACAGTCCATGC-
CATCAC-3 and 5-TCCACCACCCTGTTGCTGTA-3.
Western Blot Analysis of Rb and FBI-1—Cells were harvested
and lysed in TEN buffer (10mMTris-HCl, pH 8.0, 1 mM EDTA,
and 0.1 M NaCl). Cell extracts (40 g) were separated on a 10%
SDS-PAGE gel, transferred to Immun-BlotTM polyvinylidene
difluoridemembrane (Bio-Rad), and blockedwith 5% skimmilk
(BD Biosciences) in TBST (20 mM Tris-HCl, pH 7.5, 140 mM
NaCl, and 0.001% Tween 20) for 10 min. Blotted membranes
were incubated with Ab-FBI-1 overnight at 4 °C (Abcam),
Ab-Rb (BD Biosciences), GAPDH (Calbiochem), and Ab--tu-
bulin (Calbiochem). Membranes were further incubated with
horseradish peroxidase-conjugated anti-mouse IgG (Vector) or
anti-rabbit IgG (Vector) or anti-goat IgG (Santa Cruz Biotech-
nology), and developed with ECL reagents (PerkinElmer).
C2C12 Myoblast Cell Culture, Differentiation, and Western
Blot Analysis—Mouse C2C12 myoblast cells were maintained
in DMEM (Invitrogen) supplemented with 10% fetal bovine
serum. Stable C2C12 cells overexpressing FBI-1 were prepared
by transfecting C2C12 cells with a recombinant LentiM1.4-
FBI-1-FLAG virus. To induce differentiation of the C2C12 cells
into myotubes, mediumwas switched to DMEMwith 2% horse
serum as described elsewhere (12). For the Rb rescue experi-
ment, recombinant adenovirus overexpression Rb was pur-
chased from Vector Biolabs (Philadelphia, PA) and infected at
100 multiplicity of infection.
RESULTS
FBI-1 Represses Transcription of the Rb Gene—FBI-1 shows
proto-oncogenic activity by repressing the expression of the
tumor suppressorARF gene (21).We suspected thatARFmight
not be the only target gene of transcription repression and that
FBI-1may havemultiple additional target genes by which it can
exert oncogenic activity (22 and references therein). We inves-
tigated whether other tumor suppressor genes, such as the Rb
gene, which is critically involved in cell cycle control and tumor
suppression, is the target of FBI-1. Using the recently charac-
terized FBI-1 consensus sequence, we identified four potential
FBI-1 binding sites (FRE) on the Rb promoter. The four poten-
tial FREs are GC-rich and have varying degrees of homology
with the consensus FRE sequence with either perfect homology
or with one or two mismatches (Fig. 1A) (21, 26).
We transiently co-transfected HeLa cells with two FBI-1
expression plasmids (pcDNA3-FBI-1 and pcDNA3-FBI-1POZ)
and thepGL2-Rb-Lucplasmid, andanalyzed the luciferase activity
of these transfected cells. FBI-1 repressed transcription of Rb by
50%relative to the control. FBI-1 lacking thePOZ-domainhada
muchweaker effect, repressing the transcription ofRb by 18% rel-
ative to the control, suggesting that the POZ-domain is important
in transcriptional repression of Rb gene (Fig. 1B). In HeLa cells,
humanpapilloma virus E7 is known to influence the activity of Rb.
One may argue that FBI-1 affects papilloma virus E7 and thereby
affects Rb expression. Consequently, we carried out transcription
assays in human colon cancer HCT116 cells and HEK293A cells,
whichdonothavepapillomavirusE7. In these twocell types,FBI-1
also repressedRbgene transcription, suggesting thatFBI-1directly
acts on the Rb promoter to repress transcription (Fig. 1B).
We also investigated whether FBI-1 represses Rb gene
expression in stable HeLa and HCT116 cells overexpressing
FBI-1 due to transfection with the recombinant control Lenti-
virus, LentiM1.4-FBI-1-FLAG. RT-PCR andWestern blot anal-
ysis showed that FBI-1 decreased the mRNA and protein levels
of theRb gene, respectively, comparedwith those of the control
cells transfected with the control Lentivirus-LacZ virus (Fig. 1,
C and D, and supplement Fig. S1).
Alternatively, we tried to show whether knockdown of
endogenous FBI-1 mRNA expression could increase transcrip-
tion of Rb by removing the transcription repression by FBI-1.
Successful knockdown of endogenous FBI-1 mRNA by RNA
interference using two independent siRNAs resulted in an
increase in Rb gene transcription (Fig. 1E). RT-PCR andWest-
ern blots showed that siRNA treatment resulted in a significant
decrease in endogenous FBI-1 mRNA and FBI-1 protein and a
concomitant increase in Rb mRNA and protein expression,
respectively (Fig. 1, E–G). These data suggested that FBI-1 is a
transcriptional repressor of Rb gene expression.
FBI-1 Binds to the Rb Promoter Elements in Vivo and in Vitro—
Having shown that FBI-1 can repress Rb gene transcription,
we investigated whether FBI-1 could bind to the four poten-
tial FRE elements by EMSA and ChIP assays. Four
[-32P]dATP-labeled FRE oligonucleotide probes (bp 308
to 300, bp 298 to 290, bp 244 to 236, and bp 188
to 180) were allowed to interact with recombinant GST-
FBI-1ZFDBD (zinc finger DNA binding domain) (aa 366–
495). The FBI-1ZFDBD bound to the FRE 2, 3, and 4 probes,
but bound the FRE 1 probe very weakly compared with the
other FREs. Cold competitor oligonucleotides competed
well, and the addition of GST-specific antibody caused the
retarded band to disappear, as reported for Sp1ZFDBD, FBI-
1ZFDBD, and NF-B (Fig. 2A) (14, 27).
We further investigated whether FBI-1 binds to the endoge-
nous Rb promoter in vivo using a ChIP assay. We transfected a
FLAG-FBI-1 expression vector into HeLa cells. ChIP assays
showed that the antibody against the FLAG-tag precipitated
the distal four FRE cluster (bp 370 to 147) region. ChIP
assays with IgG antibody as a control did not result in the pre-
cipitation of the distal region of the Rb gene promoter (Fig. 2B).
FBI-1 Binds to the FREs and This Binding Is Important for
Transcription Repression—To investigate the functional
importance of FBI-1 binding to the FRE elements in vivo, we
mutated the FREs and analyzed the effect of thesemutations on
Rb gene transcription. First, we tested whether the mutations
we introduced actually prevented FBI-1 from binding to the
mutated FRE elements in vitro. We prepared mutant FRE oli-
gonucleotides inwhich the coreGGG sequence of the FREswas
replaced with AAA (Fig. 2C). We analyzed the binding interac-
tions between FBI-1 and FRE Wt or mutant FRE probes by
EMSA. FBI-1 bound well to all the FREWt probes as in Fig. 2A,
but FBI-1 did not bind to any of the mutant FREs, which indi-
cates that the core GGG sequence is critical for FBI-1 binding
(Fig. 2C).
Having shown that FBI-1ZFDBD does not bind to mutant
probes, we introducedmutations into the promoter of the Rb
gene by site-directed mutagenesis. We transiently trans-
fected HeLa cells with Wt or mutant pGL2-Rb-Luc plasmids
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to investigate the in vivo function of the FRE1–4 elements.
Mutations of all four FREs increased the transcriptional
activity of the Rb promoter compared with the Wt promoter
by 26–55%. And the transcriptional repression of the Rb
promoter by FBI-1 was significantly decreased compared
with the Wt promoter. In particular, mutation of the FRE2
sequence resulted in relatively potent derepression of Rb
transcription, indicating that FRE2 may be the most impor-
FIGURE 1. FBI-1 represses transcription of the Rb gene. A, structure of the Rb gene promoter and sequence comparison of four potential FBI-1 binding sites
(FRE). Transcription factor binding sites are indicated by circles. The FREs are located in the 180 to 308 bp region. FRE; FBI-1 binding site; Tsp (1),
transcription start site. B, structures of FBI-1 and the FBI-1with a POZ-domain deletion. FBI-1 repressed transcription of the Rb gene bymore than 50% inHeLa,
HCT116, and HEK 293A cells. POZ, POZ-domain; ZF, Kru¨ppel-like zinc fingers; NLS, nuclear localization sequence. C and D, RT-PCR andWestern blot analysis of
Rb gene repression by FBI-1 at mRNA and protein levels in stable HeLa and HCT116 cells overexpressing FBI-1 or -galactosidase. GAPDH, control for RT-PCR
andWesternblot analysis. Histogramof theqRT-PCRanalysis of FBI-1 andRbmRNA is shownbelow.NC, negative control siRNA. E, transient transcriptionassays
in HEK293A cells transfected with pGL2-Rb-Luc and siRNA designed to knock down endogenous FBI-1.Mock, negative control siRNA; GAPDH, positive control
siRNA against GAPDHmRNA; FBI-1#1 and #2, siRNAdesigned to knock down endogenous FBI-1. F andG, RT-PCR andWestern blot analysis of RNA interference
of endogenous FBI-1 mRNA and protein expression. Knockdown of FBI-1 mRNA by siRNA increased Rb gene expression both at the mRNA and protein levels
in HEK293A cells.
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tant element in FBI-1-mediated transcription repression
(Fig. 2D). In support of this, the FRE2 probe bound strongly
to FBI-1ZFDBD (Fig. 2, A and C). These data suggested that
FBI-1 acts as a transcriptional repressor of Rb by binding to
all of the FREs of the Rb gene promoter in vivo. FBI-1 binds
relatively strongly to the FRE2 element, and the FRE2 ele-
ment appears more important for transcription repression of
Rb transcription by FBI-1. Potentially the expression of Sp1
can be affected by the overexpressed FBI-1, which may affect
Rb gene transcription. Western blot showed that ectopic
FBI-1 does not affect Sp1 expres-
sion. Accordingly, the decrease in
the transcription repression was
likely caused by the decrease in
FBI-1 binding on the FREs.
FBI-1 Binding to the Sp1-binding
GC-box 2 Is Important for Transcrip-
tional Repression—Having shown
that FBI-1 is a GC-box-binding
protein that could repress Rb
gene transcription, we investi-
gated whether FBI-1 could bind to
the Sp1-binding GC-boxes of the
proximal promoter of endogenous
Rb gene in vivo, using a ChIP assay.
We transfected a FLAG-FBI-1
expression plasmid into HeLa
cells. ChIP assays showed that the
antibody against the FLAG tag
precipitated the proximal pro-
moter region (bp 131 to 93).
ChIP assays with IgG antibody as a
control did not result in precipita-
tion of the proximal region of the
Rb gene promoter (Fig. 3A). To
investigate the functional signifi-
cance of FBI-1 binding to the GC-
box element in vivo, we mutated
GC-boxes 1 and 2 and analyzed
the effect of this on Rb gene tran-
scription and also possibly on the
transcription repression by FBI-1
(Fig. 3B).
We transiently transfected HeLa
cells with Wt or mutant pGL2-Rb-
Luc plasmids to investigate in vivo
function of the Sp1-binding GC-
boxes 1 and 2. Mutation of the
Sp1-binding GC-box 1 (bp 65
and 56) reduced luciferase gene
expression compared with the Wt
Rb promoter. These data indicate
that the first Sp1 binding site is
important for transcriptional acti-
vation by Sp1, as reported previ-
ously (28). Unexpectedly, muta-
tion of the second Sp1-binding
GC-box 2 (bp 18 and 9)
resulted in increased luciferase activity compared with the
Wt Rb promoter (Fig. 3B). The data suggest that the second
Sp1-binding site may be occupied by repressors such as
FBI-1 and/or repressors of the Sp1-family. Mutation of the
GC-box 2 increased the transcriptional of the Rb promoter
by 2.2-fold compared with the Wt promoter in the presence
of FBI-1 (Fig. 3B). These data indicate that GC-box 2 may be
also the element in FBI-1-mediated transcription repression.
In support of this, the GC-box 2 probe bound strongly to
both Sp1 ZFDBD and FBI-1ZFDBD, compared with GC-box
FIGURE 2. FBI-1 binds to the distal FRE clusters of the endogenous Rb promoter. Characterization of the
functional role of the FRE elements in transcription. A, EMSA. Four 32P-labeled FRE1–4 oligonucleotide probes
(bp 308 to 300, 298 to 290, 244 to 236, and 188 to 180) were incubated with recombinant
FBI-1ZFDBD (aa 382–490) and separated on a 4%non-denaturating polyacrylamide gel. B, ChIP assays of FBI-1
binding at the FRE cluster on the endogenous Rbgene. Structure of the Rbgenepromoter and locations of PCR
primer sets used for ChIP assays. pcDNA3-FLAG-FBI-1 expression plasmid was transfected into HeLa cells, and
chromatin was immunoprecipitated with anti-FLAG antibody or control IgG. Arrows, primers used in ChIP; Tsp
(1), transcription start site. C, EMSA. Sequence comparisons of the FRE consensus sequence andmutant FRE
probes. The core GGG sequence of the FREswas substitutedwith AAA inmutant probes. EMSAwas carried out
as in A. FBI-1ZFDBD was able to bind to the wild type, but not to any of the mutant probes. D, functional
characterization of FBI-1 binding to FRE elements by transient transcription analysis in HeLa cells. Also shown
are the structures of the pGL2-Rb-Luc Wt and mutant plasmids tested. Open circles, FBI-1 binding sites; black
circles, Sp1-binding GC-boxes. X, mutation introduced. Mutations of the FREs increased transcription of Rb
gene by 20–130% compared with theWt promoter. E, Western blot analysis of Sp1 and FBI-1 in the HeLa cells
transfected and described in D.
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1 (Fig. 4, C and D). As in Fig. 2, ectopic FBI-1 does not affect
the expression of Sp1.
Identification of aNewSp1BindingElement (FRE3) in theDistal
FRE Cluster and Proximal Binding of FBI-1 to GC-box 2—
Although binding of FBI-1 to FRE1–4 and the resulting recruit-
ment of the co-repressor-HDACcomplex by FBI-1may explain
the observed transcriptional repression of Rb, binding compe-
tition between the transcriptional activator Sp1 and the tran-
scriptional repressor FBI-1 could also result in transcriptional
repression. Because the deletion of the POZ-domain of FBI-1
did not result in the complete derepression of transcription,
transcription factor binding competition toward the same reg-
ulatory element might contribute to the observed transcrip-
tional repression in HeLa cells (Fig. 1B).
Interestingly, both FBI-1 and Sp1 bind to GC-rich sequences,
andsomeof thebindingsitesmaybeboundbybothFBI-1andSp1.
First, we investigatedwhether FBI-1 could bind to the typical Sp1-
binding GC-box probe (5-GATCATTCGATCGGGGCGGGG-
CGAGC-3; underlined is the core Sp1 binding sequence) using
EMSA(29). FBI-1ZFDBDwasable tobind to the typical Sp1-bind-
ingGC-boxprobe (Fig. 4B). Furthermore,we carriedoutEMSAto
determine whether the two GC-boxes of the Rb promoter can be
bound by FBI-1. Although FBI-1ZFDBD was unable to bind to
GC-box 1, it bound to GC-box 2 (Fig. 4C), indicating that FBI-1
can bind to some GC-boxes.
In turn, we also investigated whether Sp1 could bind to some
of the FREs. We found that Sp1 bound to the FRE3 quite
strongly (Fig. 4D), which is juxtaposed with FRE2 to which
FBI-1 boundmost strongly (Fig. 2C, lane 3). Sp1 bindsweakly to
FRE1 and FRE4. Sp1 binds to GC-box 2 more strongly than to
GC-box 1 (Fig. 4, C and D).
FBI-1 and Sp1 Compete for the FRE3 and the GC-box 2 in
Vitro and in Vivo—FBI-1 bound to the GC-box 2 and Sp1 bound
to the FRE3 and GC-box 2. Thus, binding competition between
Sp1 and FBI-1 on these elements may be important in the tran-
scriptional repressionofRb gene.Therefore,weperformedEMSA
binding competition assays for the FRE3 and GC-box 2.
Sp1ZFDBD (100 ng) was added to the probes in the presence of
increasing amounts of FBI-1ZFDBD (100, 400, and 800 ng).
Increasing the amount of FBI-1 decreased the FRE3-Sp1 or GC-
box 2-Sp1 interaction, demonstrating molecular competition
between FBI-1 and Sp1 (Fig. 4E). Interestingly, FBI-1 competed
effectively forGC-box2 comparedwithFRE3, again indicating the
strong binding affinity of Sp1 for FRE3.
ChIPAssays Reveal that FBI-1 and Sp1Compete for the FRE 3
Element and GC-box 2 of the Rb Gene Promoter in Vivo—We
investigated themolecular competition between FBI-1 and Sp1
on the endogenousRb promoter and 3-untranslated regions in
human kidneyHEK293A cells. ChIP assays of the proximal pro-
moter region containing GC-boxes 1 and 2, and also of the
distal promoter region containing four FREs, showed that Sp1
binding to the Rb promoter regions is decreased and FBI-1
binding is increased, as an increasing amount of FBI-1 expres-
sion vector is co-transfected (Fig. 5B). Additionally, we knocked
down the expression of endogenous FBI-1mRNA and analyzed
the promoter binding by FBI-1 and Sp1 on the endogenous Rb
promoter by ChIP. Knockdown of FBI-1 expression decreased
FBI-1 binding both on the proximal and distal FBI-1 binding
regions, whereas Sp1 binding on the two regulatory regions was
increased (Fig. 5D). In the control 3-UTR region, no ChIP or
binding competition was observed (Fig. 5, B and D). The data
again support the idea that FBI-1 and Sp1 can compete with
each other in binding to the FRE 3 element andGC-box 2 of the
Rb promoter in vitro and also in vivo (Figs. 4E and 5, B–D).
FIGURE 3. FBI-1 binds to the proximalRbpromoter andmay repress tran-
scription via the GC-box 2 in vivo. A, ChIP assays of FBI-1 binding at the
proximal promoter (bp131 to93) of the endogenous Rb gene. Structure
of the Rb gene promoter and locations of PCR primer sets used for ChIP
assays. pcDNA3-FLAG-FBI-1 expression plasmid was transfected into HeLa
cells and chromatin was immunoprecipitated with anti-FLAG antibody or
control IgG. Arrows, primers used in ChIP; Tsp (1), transcription start site.
B, structures of pGL2-Rb-LucWt andmutant plasmids and transcription anal-
ysis. Mutations were introduced into the proximal promoter. Open circles,
FBI-1 binding sites; filled black circles, Sp1-binding GC-boxes; X, mutation
introduced. Mutation of the GC-box 1 decreased transcription, but mutation
ofGC-box 2 increasedRbgene transcription comparedwith theWtpromoter,
which suggests that FBI-1 may bind to GC-box 2 and repress transcription.
C, Western blot analysis of Sp1 and FBI-1 in the HeLa cells transfected and
described in B.
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We also investigated the molecular competition between
FBI-1 and Sp1 on the Rb promoter in Drosophila SL2 cells.
pGL2-Rb-Luc and pPac-Sp1 expression vectors and increasing
amounts of pPac-FBI-1 expression vector were co-transfected
intoDrosophila SL2 cells that do not express mammalian tran-
scription factors. ChIP assays of the proximal promoter region
and the distal promoter region showed that Sp1 binding to the
Rb promoter regions is decreased as an increasing amount of
FBI-1 expression vector is co-trans-
fected (supplemental Fig. S2A).
ThePOZ-domainofFBI-1 Interacts
with the Co-repressors in Vitro and in
Vivo—Because FBI-1 represses tran-
scription of the Rb gene, we investi-
gated whether the POZ-domain,
which is important in transcriptional
repression, interacted with the co-re-
presssors using mammalian two-hy-
brid assays. We co-transfected CV-1
cells with pGal4-POZFBI-1, the
reporter gene construct (pG5-Luc),
and the pVP16AD-co-repressor
(BCoR, NCoR, and SMRT) and ana-
lyzed for reporter luciferase activity.
We found that the POZ-domain of
FBI-1 was able to interact with BCoR,
NCoR, andSMRT(Fig. 6A).To inves-
tigate whether the molecular interac-
tion between the POZ-domain and
the co-repressorswas direct, we incu-
bated recombinant GST-POZFBI-
1or GST with in vitro synthesized
[35S]methionine-labeled co-repres-
sors and performed a pulldown assay.
GST-POZFBI-1 interacted with
BCoR, SMRT, and NCoR, suggesting
that the molecular interaction
betweenthePOZ-domainandtheco-
repressors is direct (Fig. 6B).
Furthermore, we also examined
whether FBI-1 can interact with
a co-repressor by performing co-
immunoprecipitation assays for
BCoR. Cell extracts prepared from
HEK293A cells transfected with
FLAG-FBI-1 and/or Myc-BCoR
expression vector were immuno-
precipitated using anti-Myc anti-
body and analyzed by Western
blot assay using antibody against
Myc or FLAG. FBI-1 and BCoR
interact with each other in vivo
(Fig. 6C). Furthermore, we investi-
gated whether the BCoR co-re-
pressor is associated with the Rb
gene promoter in an FBI-1-
dependent manner. We trans-
fected HEK293A cells with FLAG-
FBI-1 or/and Myc-BCoR expression vectors. ChIP assays
showed that BCoR binding to the FRE cluster (bp 370 to
147) was significantly increased in the presence of FBI-1.
In contrast, in the absence of co-expressed FBI-1, BCoR
binding was very weak. In the 3-UTR control region, no
ChIP of BCoR or FBI-1 was observed. These data suggested
that the co-repressor BCoR was recruited by FBI-1 bound on
the FRE cluster (Fig. 6D).
FIGURE 4. FBI-1 binds to theproximal Sp1-bindingGC-box 2, andSp1binds to thedistal FRE3 element in
vitro. FBI-1 and Sp1 compete with each other for binding to FRE3 and GC-box 2. A, comparisons of the nucle-
otide sequences of the FREs and Sp1-binding GC-boxeswith their consensus sequences. B, EMSA. FBI-1ZFDBD
was incubatedwith FRE4 or the typical Sp1 GC-box probe. FBI-1 binds to the Sp1-binding GC-box probe. FRE4,
control FBI-1 binding probe. Sp1 GC-box, a typical Sp1-binding oligonucleotide probe with 5-GGGCGGGG-3
core sequence. C, EMSA. Recombinant Sp1ZFDBD or FBI-1ZFDBDwas incubated with the GC-box probes. Sp1
binds both GC-box 1 and 2, but bindsmore strongly to GC-box 2 (lanes 2 and 7). FBI-1 binds to the Sp1 GC-box
2probeonly.D, EMSAand identificationof a newSp1binding element, FRE3. Recombinant Sp1ZFDBD (0.1g)
was incubatedwith the FREprobes or theGC-boxprobes. Sp1 significantly binds to FRE3 andGC-box 2probes.
E, EMSA. FBI-1 and Sp1 compete for binding to FRE3 and GC-box 2 in vitro. The probes were incubated with
Sp1ZFDBD (0.1g) in the presence of increasing amounts of FBI-1ZFDBD (0.1, 0.4, and 0.8g). FBI-1 competes
with Sp1 for binding to FRE3 and GC-box 2 in vitro.
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The FBI-1-co-repressor-HDAC Interaction Deacetylates Both
Ac-H3 andAc-H4 at the Proximal Promoter Region of the RbGene
in Vivo—Because co-repressors repress transcription by recruit-
ing HDACs, the molecular interaction between FBI-1 and co-re-
pressorsmay be of importance in the transcriptional repression of
theRb gene by FBI-1. Accordingly, we investigatedwhether FBI-1
could deacetylate Ac-H3 and Ac-H4
histones bound at the proximal pro-
moter region (bp 131 to 167).
The ChIP assay showed that FBI-1
decreased acetylated histones 3
and 4 at the proximal promoter.
The data suggest that histone
deacetylation at the Rb proximal
promoter is probably responsible
for transcriptional repression by
the complex containing FBI-1-co-
repressor-HDAC (Fig. 7).
Transcriptional Repression of Rb
by FBI-1 InhibitsMyogenic Differen-
tiation of C2C12 Myoblasts into
Myotubes—Having shown that
FBI-1 can repress Rb gene expres-
sion, we examined whether FBI-1
can affect the cellular processes
controlled by Rb, such as myogenic
differentiation. First, C2C12 cells
were induced to differentiate by
treatment with 2% horse serum.We
analyzed the changes in the expres-
sion of Rb and FBI-1 by Western
blot analysis. As C2C12 cells dif-
ferentiated into myotubes, Rb
gene expression increased and
FBI-1 expression decreased (sup-
plemental Fig. S3), suggesting a
possible correlation between the
two factors.
We examined the effect of
ectopic FBI-1 expression on myo-
blast differentiation. We prepared
stable cell lines by transfecting
C2C12 cells with either recombi-
nant Lenti-LacZ control virus or
LentiM1.4-FLAG-FBI-1 virus. The
stable control and FLAG-FBI-1
C2C12 myoblasts cells were treated
with 2%horse serum to induce them
to differentiate into myotubes. At
day 0 of differentiation induction,
there was no apparent change in the
myoblast cell shape. However, after
3–4 days of culturing with differenti-
ation medium, the cells showed
marked differences in cell morphol-
ogy. Abundant multinucleated myo-
tubeswere formed in thecontrol cells,
whereas very fewmyotubeswere seen
in C2C12 cells overexpressing FLAG-FBI-1. Western blot of the
cell lysates at days 2–4 of differentiation showed that Rb protein
was significantly decreased in the stable C2C12 cells (Fig. 8).
Alternatively, we also examined whether inhibition of myo-
genic differentiation by transcription repression of Rb gene by
FBI-1 could be rescued by transfection with recombinant ade-
FIGURE 5. ChIP assays. FBI-1 and Sp1 compete with each other for binding to FRE3 and GC-box 2 in vivo.
A, structure of human Rb gene. Arrows, primers used in ChIP; Tsp (1), transcription start site. Circles with
number, FBI-1 binding FREs; filled black circleswith number, GC-box that binds Sp1; open boxes, exons; 3-UTR,
3-untranslated region with no known binding sites for either Sp1 or FBI-1. B, ChIP assays of binding competi-
tionbetweenSp1andFBI-1 for thedistal (bp370 to147), proximal promoter (bp,131 to93), and3-UTR
elements (bp176326 to176626) of the endogenous Rb gene promoter in HEK293A cells. HumanHEK293A
cells were transfectedwith increasing amount of FLAG-FBI-1 expression vector and analyzed for Sp1 and FBI-1
bindingusing theantibodies indicated. Sp1andFBI-1 competewitheachotherbothon thedistal andproximal
promoter regions. C, histogram of the ChIP assay shown in B. D, ChIP assays on the endogenous Rb gene
promoter after knockdown of endogenous FBI-1 expression in HEK293A cells. Knockdown of FBI-1 resulted in
an increase in Sp1 binding to the endogenous Rb gene promoter, both on the proximal and distal promoters.
E, histogram of the ChIP assay shown in C.
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novirus overexpressing Rb in the stable C2C12-FBI-1 myo-
blasts cells. After 2–4 days of culturing with differentiation
medium, the cells showed differences in cell morphology and
many myotubes were formed in the Rb rescued stable C2C12-
FBI-1 cells, whereas few myotubes were seen in C2C12-FBI-1
cells transfected with control adenovirus. Western blot of the
cell lysates at days 0 and 4 of differentiation showed that Rb
protein was significantly increased in the rescued stable
C2C12-FBI-1 cells (Fig. 9). Our data
suggest that FBI-1 repressesRb gene
expression and thereby blocks
myogenic differentiation of C2C12
myoblasts.
DISCUSSION
We are interested in determining
and characterizing the biological
functions of FBI-1 (14, 20). Recently,
FBI-1 was characterized as a proto-
oncogene causingmultiple cancers in
the thymus, liver, and spleen. FBI-1
repressesARFgeneexpression,which
in turns results in the repression of
the tumor suppressor p53 (21). We
investigated whether FBI-1 has addi-
tional target genes through which it
can exert its oncogenic activity. Ini-
tially, we suspected that FBI-1 might
regulate other genes that have critical
roles in oncogenesis and differentia-
tion, such as Rb, a tumor suppressor
gene that regulates theG1 checkpoint
of the cell cycle (6 and references
therein). Most functional studies of
Rb have been performed at the pro-
tein level. However, investigations
into how transcription of the Rb gene
is regulated are also important for
understanding the cellular regulation
of Rb functions (8–12).
We found that FBI-1 can potently
repress Rb gene transcription, and its
POZ-domain is important for this
transcription repression. The POZ-
domain of FBI-1 interacts with co-re-
pressors such as BCoR, NCoR, and
SMRT. Co-represssors in turn inter-
act with HDACs, which suggests that
FBI-1 may recruit HDACs through
co-repressors to deacetylate histones
H3 and H4 around the proximal pro-
moter region of the Rb gene, thereby
repressing Rb transcription.
We also found that the FBI-1 is a
GC-box-binding protein and binds
directly toFRE-1, -2, -3, and -4.Unex-
pectedly, we also found that FBI-1
binds to GC-box 2. Among the GC-
rich FREs and two GC-boxes, FRE1–4, and GC-box 2 are impor-
tant for transcriptional repression by FBI-1. FBI-1 bound to the
FRE2most strongly, andmutationofFRE2resulted inpotentdere-
pression. Therefore, FBI-1 might repress transcription of the
Rb gene primarily by binding to the FRE2 and by recruiting
co-repressors.
The FBI-1 binding consensus sequence (5-GDGGGYYYY-3)
and Sp1 consensus sequence (5-KRGGMGKRRY-3) are
FIGURE 6. FBI-1 interacts with the co-repressors via its POZ-domain, and BCoR is recruited to the pro-
moter by FBI-1. A, diagram of themammalian two-hybrid assay and protein-protein interaction between the
POZ-domain of FBI-1 and the co-repressors. Upstream activating sequence (UAS), binding site for Gal4DBD (B)
GST fusion protein pulldown assays and structure of the co-repressors SMRT, NCoR, BCoR, and FBI-1. GST and
GST-POZFBI-1 fusion proteins were incubated with in vitro synthesized [35S]methionine-labeled co-repressor
polypeptides and pulled down. RD, repression domain; N3-1 and S1–2, domains involved in interaction with
nuclear receptors; ZF, zinc finger domain; POZ, POZ-domain of FBI-1. Domains of co-repressors used for in vitro
pulldown assays are indicated below by light gray filled bars. C, co-immunoprecipitation of FBI-1 and BCoR. Cell
lysates prepared from HEK293A cells transfected with FLAG-FBI-1 and Myc-BCoR expression vectors were
immunoprecipitated using anti-Myc antibody and analyzed by Western blotting using anti-FLAG antibody.
D, ChIP assays of BCoR and FBI-1 binding at the distal FRE elements and 3-UTR of Rb gene. HEK293A cells were
transfectedwith FLAG-FBI-1 and/orMyc-BCoR expression vector and immunoprecipitatedwith the antibodies
indicated. More BCoR is bound to the FRE cluster in the presence of FBI-1. A histogram of the ChIP assays is
shown on the right.
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GC-rich (21,26,29). Sp1binds toFRE3,andFBI-1bindsGC-box2.
Sp1 andFBI-1 share some regulatory elements that are rich inGC,
and binding competition between the two factors for these ele-
mentsmay determine the level of transcription. EMSAand in vivo
ChIP assay data suggested that transcription of theRb gene can be
repressed by competitive binding between Sp1 and FBI-1 for ele-
ments in the proximal and distal promoter regions.
Rb gene transcription can be repressed by the combination of
two molecular mechanisms: binding competition between
FBI-1 and Sp1, and recruitment of co-repressors by the FBI-1
anchored onto FREs and/or GC-box 2. Based on our findings,
we propose a hypothetical molecular mechanism of transcrip-
tional regulation of the Rb gene by FBI-1 (Fig. 10). In cases
where FBI-1 is highly expressed, such as in cancer cells, FBI-1
binds to FRE2 (and other FREs, but with slightly lower binding
affinity) and GC-box 2 by competition with Sp1, thereby signif-
icantly decreasing Rb transcription; FBI-1 may also bind to
FRE2, which does not involve binding competition with Sp1.
Once anchored to FRE2, FRE3, FRE1, FRE4, and GC-box 2, the
FIGURE 7.FBI-1deacetylates histonesAc-H3andAc-H4at theproximal pro-
moteroftheendogenousRbgenepromoter.ChIPassaysofH3andH4histone
modificationat theproximalpromoter (bp131to167)of theendogenousRb
geneusingantibodies againstAc-H3andAc-H4.HEK293Acellswere transfected
withFLAG-FBI-1expressionvector, and immunoprecipitatedwith theantibodies
indicated. A histogramof the ChIP assay is shownbelow.
FIGURE8.FBI-1 inhibitsmouseC2C12myoblastdifferentiationby inhibiting
Rb gene expression. A, differentiation of control mouse C2C12 myoblasts and
stable C2C12 myoblasts overexpressing FLAG-FBI-1, by horse serum treatment.
Pictures of the cellswere takenatdays 0–4after treatmentwith2%horse serum
differentiationmedium.Differentiation intomyotubeswasobservedonly incon-
trol cells at days 3 and 4. Stable C2C12myoblast cells overexpressing FBI-1 were
prepared by transfection with either control lentri virus or recombinant Lenti-
M1.4-FLAG-FBI-1virus.B,Westernblotanalysisof theC2C12cell lysatesusing the
antibodies indicated. Rb expression was gradually increased in the control cells
with concomitant decrease in FBI-1 (LRF). LRF is a mouse homologue of human
FBI-1. In the stable cells, although endogenous LRF is decreased, FLAG FBI-1 is
stably expressed and repressed Rb expression. Cell extracts (40 g) were ana-
lyzed by Western blot analysis. GAPDH, control; Rb, retinoblastoma protein.
C, myogenic differentiation is inhibited by FBI-1 in the stable C2C12-FLAG-FBI-1
cells. However, control cells underwent myogenic differentiation and showed
multinuclearmyotubes at days 3–4.
FIGURE 9. Inhibition of mouse C2C12 myoblast differentiation by FBI-1
can be rescued by transfection with recombinant adenovirus overex-
pressing Rb gene. A, differentiation of control mouse C2C12 myoblasts and
stable C2C12 myoblasts overexpressing FLAG-FBI-1, by horse serum treat-
ment. Pictures of the cells were taken at days 0, 2, and 4 after treatment with
2% horse serum differentiation medium. Differentiation into myotubes was
observed only in control cells at day 4. Stable C2C12 myoblast cells overex-
pressing FBI-1 were differentiation into myotubes only when transfected
with recombinant adenovirus overexpressing Rbgene at day 4, but not in the
cells rescued with control adenovirus. Ad, recombinant adenovirus. B, West-
ern blot analysis of the C2C12 control or C2C12-FBI-1 cell lysates using the
antibodies indicated. Rb expression was increased in the control cells with
concomitant decrease in FBI-1 (LRF). LRF is a mouse homologue of human
FBI-1. In the stable cells, althoughendogenous LRF is decreased, FLAGFBI-1 is
stably expressed and repressed Rb expression. Transfection with recombi-
nant adenovirus increases Rb expression both in control and stable cells. Cell
extracts (40 g) were analyzed by Western blot analysis. GAPDH, control; Rb,
retinoblastoma protein.
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POZ-domain of FBI-1 can then recruit a co-repressor-HDAC
complex, further repressing transcription through histone
deacetylation.
When FBI-1 expression levels are low as in normal cells,
FBI-1 cannot compete with Sp1 for FRE3 and GC-box 2, and
these sites are open for Sp1 binding. The binding of Sp1 to
FRE3, GC-box 1, and GC-box 2, will likely activate transcrip-
tion of the Rb gene, and a certain cellular level of Rb gene tran-
scription corresponding to the Sp1 level will be maintained.
Also, transcription activators such as Sp1, ATF2, CREB1, and
E2F1 bound at the65 to41 bp region can transcriptionally
activate Rb resulting in cellular levels of Rb gene transcription
(2–6).
Cellular regulators that regulate Rb gene expression can sig-
nificantly affect cellular functions controlled by Rb. For exam-
ple, MyoD via CREB induces Rb gene promoter transcription,
which is a key event for muscle cell differentiation (9). Con-
versely, MIZF and YY1 repress transcription of Rb and inhibit
muscle formation (10, 12, 23). In this report, we have shown
that FBI-1 interferes withmyoblastic C2C12 cell differentiation
by inhibitingRb gene transcription.We expect that FBI-1 could
regulate other cellular functions such as the cell cycle, oncogen-
esis, and cell differentiation, by repressing Rb gene expression.
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FIGURE 10. Hypothetical regulatory mechanism for the transcriptional
regulation of Rb gene by FBI-1 and Sp1.When FBI-1 is highly expressed as
in cancer cells, FBI-1 binds to the distal FREs andGC-box 2 on the Rbpromoter
by competing with Sp1. FBI-1 preferentially binds to FRE2 (). After FBI-1
binding, the co-repressor-HDAC complex is recruited by the POZ-domain of
FBI-1 and represses transcription by deacetylating histones H3 and H4 of the
nucleosomes around the proximal promoter. When FBI-1 is low, as in normal
cells, Sp1 binds to FRE3 (††), a newly identified strong Sp1-binding element,
GC-box 1, and GC-box 2 to activate transcription. FRE, FBI-1 binding element;
GC-box, Sp1-bindingGC-rich element; , high affinity FBI-1 binding element; ,
high affinity FBI-1 binding GC-box2 element; ††, a newly identified high affinity
Sp1-bindingelement;Tsp (1), transcriptionstart site; transcriptionrepression
by histonemodification at the proximal promoter.
Proto-oncogene FBI-1, a Transcription Repressor of Rb
33210 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 283•NUMBER 48•NOVEMBER 28, 2008
 at Y
O
N
SEI U
N
IV
ERSITY
 on O
ctober 29, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
